Modified influenza M158–66 peptide vaccination induces non-relevant T-cells and may enhance pathology after challenge

Josien Lanfermeijer(University Medical Center Utrecht), Jørgen de Jonge(National Institute for Public Health and the Environment)

npj Vaccines

August 12, 2023

10.1038/s41541-023-00705-y

Cited by 3

Related Papers

A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets

|Science Advances|2022|63

Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets

|PLoS ONE|2015|35